Invention Application
- Patent Title: ANTIBODY TARGETING CD22 AND CD79B
-
Application No.: US17702042Application Date: 2022-03-23
-
Publication No.: US20220306738A1Publication Date: 2022-09-29
- Inventor: Kyle J. Bednar , Naresh Kumar , Sanjaya Singh , Danlin Yang , Rajkumar Ganesan
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/46
Abstract:
Provided herein are multispecific antibodies, that bind to CD79b and CD22, polynucleotides encoding them, vectors, host cells, methods of making and using them.
Public/Granted literature
- US12180278B2 Antibody targeting CD22 and CD79B Public/Granted day:2024-12-31
Information query
